Patent Foramen Ovale (PFO) Closure Devices Market
During the projected period, new product introductions are expected to drive growth in the Patent Foramen Ovale (PFO) closure device market. For example, W. L. Gore & Associates, Inc. got US FDA approval in April 2018 for its GORE CARDIOFORM Septal Occluder for PFO closure to avoid recurrent ischemic stroke. When PFO closure was paired with antiplatelet medication, the study claimed a 77% reduction in recurrent ischemic stroke when compared to antiplatelet therapy alone. Furthermore, after a product recall, the Amplatzer PFO Occluder device was reintroduced in 2016 with FDA approval to lower stroke risk in patients with past cryptogenic stroke.
Read More:
https://knackersblogger.blogspot.com/2022/09/patent-foramen-ovale-pfo-closure.html
